Long term outcomes of intracarotid arterial transfusion of circulatory-derived autologous CD34 + cells for acute ischemic stroke patients—A randomized, open-label, controlled phase II clinical trial
Intracarotid transfusion of autologous CD34 + cells is safe and might improve long-term outcomes in patients with acute IS. Trial registration ISRCTN, ISRCTN15677760. Registered 23 April 2018- Retrospectively registered, https://doi.org/10.1186/ISRCTN15677760.
Authors
- John Y. Chiang (ORCID: https://orcid.org/0000-0002-8719-4017)
- Pei‐Hsun Sung (ORCID: https://orcid.org/0000-0002-1989-9752)
- Sheung‐Fat Ko (ORCID: https://orcid.org/0000-0002-9524-6999)
- Hon‐Kan Yip (ORCID: https://orcid.org/0000-0002-6305-5717)
- Fan-Yen Lee (ORCID: https://orcid.org/0000-0002-2335-0172)
- Hung-Sheng Lin
- Wei-Che Lin (ORCID: https://orcid.org/0000-0002-5258-8569)
- Kuan‐Hung Chen (ORCID: https://orcid.org/0000-0002-2527-2825)
- Yi‐Ling Chen (ORCID: https://orcid.org/0000-0002-9789-2441)
- Shu‐Hua Huang (ORCID: https://orcid.org/0000-0001-6542-5315)
- Ming‐Chun Ma
Institutions
- National Sun Yat-sen University (TW)
- Kaohsiung Medical University (TW)
- Chang Gung University (TW)
- China Medical University (TW)
- Kaohsiung Chang Gung Memorial Hospital (TW)
- Ministry of Health and Welfare (TW)
- China Medical University Hospital (TW)
Publication Details
- Journal
- Stem Cell Research & Therapy
- Published
- 2024-11-20
- DOI
- https://doi.org/10.1186/s13287-024-04021-7
- Citations
- 4
- Primary Topic
- Angiogenesis and VEGF in Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- Chang Gung Medical Foundation
- Kaohsiung Chang Gung Memorial Hospital